Literature DB >> 2990322

Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro.

S Benes, W M McCormack.   

Abstract

We evaluated the ability of the widely used spermicide nonoxynol-9, Conceptrol gel containing nonoxynol-9, and Conceptrol vehicle (without nonoxynol-9) to inhibit the formation of inclusions of Chlamydia trachomatis in cycloheximide-treated McCoy cells. Conceptrol vehicle produced a non-dose-related 40 to 59% reduction of the number of inclusions formed. In contrast, the addition of nonoxynol-9 and Conceptrol gel containing nonoxynol-9 at a concentration of 100 micrograms/ml reduced the number of inclusions by 84 to 95%. Prolongation of contact between nonoxynol-9 and the chlamydial organisms from 90 to 180 min did not result in additional inhibition. Using a higher concentration of chlamydial organisms and diluting the drug-chlamydia mixture before inoculation of the monolayers, we were able to test higher concentrations of nonoxynol-9. At concentrations of 100 to 5,000 micrograms of nonoxynol-9 per ml, a dose-related 19 to 84% reduction of the number of inclusions was noted.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990322      PMCID: PMC180141          DOI: 10.1128/AAC.27.5.724

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  The quantity of vaginal fluid.

Authors:  A STONE; C J GAMBLE
Journal:  Am J Obstet Gynecol       Date:  1959-08       Impact factor: 8.661

2.  Virucidal effect of certain chemical contraceptives on Type 2 herpesvirus.

Authors:  B Singh; B Posti; J C Cutler
Journal:  Am J Obstet Gynecol       Date:  1976-10-15       Impact factor: 8.661

3.  Nonoxynol 9 cream for genital herpes simplex.

Authors:  H J Donsky
Journal:  N Engl J Med       Date:  1979-02-15       Impact factor: 91.245

4.  Inactivation of herpes simplex viruses by nonionic surfactants.

Authors:  S S Asculai; M T Weis; M W Rancourt; A B Kupferberg
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

Review 5.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

6.  Vaginal spermicides and gonorrhea.

Authors:  H Jick; M T Hannan; A Stergachis; F Heidrich; D R Perera; K J Rothman
Journal:  JAMA       Date:  1982-10-01       Impact factor: 56.272

7.  Three novel manifestations of chlamydia trachomatis infection- endometritis, perihepatitis and meningoencephalitis.

Authors:  P A Mårdh; P Wølner-Hanssen
Journal:  Infection       Date:  1982       Impact factor: 3.553

8.  Comparison of methods for cultivation and isolation of Chlamydia trachomatis.

Authors:  S Benes; W M McCormack
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

  8 in total
  18 in total

1.  Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases.

Authors:  S Roy; P Gourde; J Piret; A Désormeaux; J Lamontagne; C Haineault; R F Omar; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Solubilization and in vitro spermicidal assessment of nonoxynol-9 and selected fractions using rabbit spermatozoa.

Authors:  B A Walter; A A Hawi; P M Zavos; G A Digenis
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

3.  Nonoxinol 9 and HIV infection.

Authors:  D J Jeffries
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

Review 4.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

Review 5.  Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review.

Authors:  L C d'Oro; F Parazzini; L Naldi; C La Vecchia
Journal:  Genitourin Med       Date:  1994-12

6.  Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro.

Authors:  H Thormar; G Bergsson; E Gunnarsson; G Georgsson; M Witvrouw; O Steingrímsson; E De Clercq; T Kristmundsdóttir
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

7.  In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides.

Authors:  G Bergsson; J Arnfinnsson; S M Karlsson; O Steingrímsson; H Thormar
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

8.  Effects of antimicrobial agents on growth and chemotaxis of Trichomonas vaginalis.

Authors:  B Sugarman; N Mummaw
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

9.  Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing.

Authors:  M C Skinner; W E Stamm; M L Lampe
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

10.  In vitro activity of nonoxynol 9 on HeLa 229 cells and primary monkey cervical epithelial cells infected with Chlamydia trachomatis.

Authors:  D L Patton; S K Wang; C C Kuo
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.